news
11-08-2023, 05:40 PM
FDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider use of blockbuster drug (https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTEvMDgvZm RhLWFwcHJvdmVzLWVsaS1saWxseS1kcnVnLXRpcnplcGF0aWRl LWZvci1vYmVzaXR5Lmh0bWzSAVxodHRwczovL3d3dy5jbmJjLm NvbS9hbXAvMjAyMy8xMS8wOC9mZGEtYXBwcm92ZXMtZWxpLWxp bGx5LWRydWctdGlyemVwYXRpZGUtZm9yLW9iZXNpdHkuaHRtbA ?oc=5) CNBC
Zepbound: FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name (https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmNubi5jb20vMjAyMy8xMS8wOC9oZW FsdGgvemVwYm91bmQtbW91bmphcm8tZmRhLWFwcHJvdmFsLW9i ZXNpdHkvaW5kZXguaHRtbNIBAA?oc=5) CNN
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy (https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3Lm5iY25ld3MuY29tL2hlYWx0aC9oZW FsdGgtbmV3cy9lbGktbGlsbHktd2VpZ2h0LWxvc3MtZHJ1Zy16 ZXBib3VuZC1mZGEtYXBwcm92YWwtb3plbXBpYy1yY25hMTIzMT Y50gEraHR0cHM6Ly93d3cubmJjbmV3cy5jb20vbmV3cy9hbXAv cmNuYTEyMzE2OQ?oc=5) NBC News
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems | Eli Lilly and Company (https://news.google.com/rss/articles/CBMid2h0dHBzOi8vaW52ZXN0b3IubGlsbHkuY29tL25ld3Mtcm VsZWFzZXMvbmV3cy1yZWxlYXNlLWRldGFpbHMvZmRhLWFwcHJv dmVzLWxpbGx5cy16ZXBib3VuZHRtLXRpcnplcGF0aWRlLWNocm 9uaWMtd2VpZ2h00gEA?oc=5) Investors | Eli Lilly and Company
FDA approves new obesity drug from Eli Lilly named Zepbound (https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9oZW FsdGgvMjAyMy8xMS8wOC9tb3VuamFyby16ZXBib3VuZC1mZGEt YXBwcm92YWwtb2Jlc2l0eS_SAQA?oc=5) The Washington Post
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lQdT lfWUNSRWthalNfaWVDS0xTZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)
More... (https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTEvMDgvZm RhLWFwcHJvdmVzLWVsaS1saWxseS1kcnVnLXRpcnplcGF0aWRl LWZvci1vYmVzaXR5Lmh0bWzSAVxodHRwczovL3d3dy5jbmJjLm NvbS9hbXAvMjAyMy8xMS8wOC9mZGEtYXBwcm92ZXMtZWxpLWxp bGx5LWRydWctdGlyemVwYXRpZGUtZm9yLW9iZXNpdHkuaHRtbA ?oc=5)
Zepbound: FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name (https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmNubi5jb20vMjAyMy8xMS8wOC9oZW FsdGgvemVwYm91bmQtbW91bmphcm8tZmRhLWFwcHJvdmFsLW9i ZXNpdHkvaW5kZXguaHRtbNIBAA?oc=5) CNN
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy (https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3Lm5iY25ld3MuY29tL2hlYWx0aC9oZW FsdGgtbmV3cy9lbGktbGlsbHktd2VpZ2h0LWxvc3MtZHJ1Zy16 ZXBib3VuZC1mZGEtYXBwcm92YWwtb3plbXBpYy1yY25hMTIzMT Y50gEraHR0cHM6Ly93d3cubmJjbmV3cy5jb20vbmV3cy9hbXAv cmNuYTEyMzE2OQ?oc=5) NBC News
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems | Eli Lilly and Company (https://news.google.com/rss/articles/CBMid2h0dHBzOi8vaW52ZXN0b3IubGlsbHkuY29tL25ld3Mtcm VsZWFzZXMvbmV3cy1yZWxlYXNlLWRldGFpbHMvZmRhLWFwcHJv dmVzLWxpbGx5cy16ZXBib3VuZHRtLXRpcnplcGF0aWRlLWNocm 9uaWMtd2VpZ2h00gEA?oc=5) Investors | Eli Lilly and Company
FDA approves new obesity drug from Eli Lilly named Zepbound (https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9oZW FsdGgvMjAyMy8xMS8wOC9tb3VuamFyby16ZXBib3VuZC1mZGEt YXBwcm92YWwtb2Jlc2l0eS_SAQA?oc=5) The Washington Post
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lQdT lfWUNSRWthalNfaWVDS0xTZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)
More... (https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTEvMDgvZm RhLWFwcHJvdmVzLWVsaS1saWxseS1kcnVnLXRpcnplcGF0aWRl LWZvci1vYmVzaXR5Lmh0bWzSAVxodHRwczovL3d3dy5jbmJjLm NvbS9hbXAvMjAyMy8xMS8wOC9mZGEtYXBwcm92ZXMtZWxpLWxp bGx5LWRydWctdGlyemVwYXRpZGUtZm9yLW9iZXNpdHkuaHRtbA ?oc=5)